0 results available. Select is focused ,type to refine list, press Down to open the menu,
No data available
No data available
No data available
No data available
The chart above depicts the distribution of fair value uncertainty (finbox) for companies operating in the Healthcare sector in the Developed economic region. Over 1,870 companies were considered in this analysis, and 1,797 had meaningful values. The average fair value uncertainty (finbox) of companies in the sector is -53.76806430722616 with a standard deviation of 224.61046231089117.
Inozyme Pharma Inc's Fair Value Uncertainty (FINBOX) of -18.583663188197193 ranks in the 26.6% percentile for the sector. The following table provides additional summary stats:
| Economic Risk Region | Developed |
| Total Constituents | 1,871 |
| Included Constituents | 1,797 |
| Min | -2092.084716796875 |
| Max | 422.63751220703125 |
| Median | -1.7813761665707541 |
| Mean | -53.76806430722616 |
| Standard Deviation | 224.61046231089117 |
You can find companies with similar fair value uncertainty (finbox) using this stock screener.